Powered by


                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS







   Forum Archives





















   Primary Care






   Other Sections


   Research Tools

   Medical Tutorials

   Medical Software




Back to index

Cancer Chemotherapy Regimen for Non-small Cell Lung Cancer

  cytoxan......... 300 mg/sqm IV on days 1 and 8.
  adriamycin...... 20 mg/sqm IV on days 1 and 8.
  methotrexate.... 15 mg/sqm IV on days 1 and 8.
  procarbazine.... 100 mg/day orally for 10 days.
  FREQUENCY....... Repeat cycle every 28 days.

    Bitran JD.  Desser RK.  DeMeester TR.  Colman M.  Evans R. 
    Billings A.  Griem M.  Rubenstein L.  Shapiro C.  Golomb HM. 
    Cyclophosphamide, adriamycin, methotrexate, and procarbazine 
    (CAMP)--effective four-drug combination chemotherapy for 
    metastatic non-oat cell bronchogenic carcinoma. Cancer 
    Treatment Reports.  60(9):1225-30, 1976 Sep. 
    Twenty-three patients with metastatic non-oat cell 
    bronchogenic carcinoma (MNOBC) were treated with 
    cyclophosphamide, adriamycin, methotrexate, and procarbazine 
    (CAMP) after radiation therapy. Objective responses were seen 
    in 11 of 23 patients (48%) with a projected median survival 
    time of 12.5 months for responding patients and patients with 
    stable disease. Lung, liver, and cutaneous sites of 
    involvement proved to be highly responsive; bone involvement 
    was less responsive. CAMP is an effective combination in the 
    treatment of MNOBC and its use in patients with less advanced 
    disease should be explored. 

advertisement.gif (61x7 -- 0 bytes)

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 advertisement.gif (61x7 -- 0 bytes)




We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.